These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32791395)

  • 21. Cancer Stem Cells: Basic Concepts and Therapeutic Implications.
    Nassar D; Blanpain C
    Annu Rev Pathol; 2016 May; 11():47-76. PubMed ID: 27193450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Cancer Stemness in the Clinic: From Hype to Hope.
    Saygin C; Matei D; Majeti R; Reizes O; Lathia JD
    Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance.
    Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X
    Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.
    Tang YA; Chen YF; Bao Y; Mahara S; Yatim SMJM; Oguz G; Lee PL; Feng M; Cai Y; Tan EY; Fong SS; Yang ZH; Lan P; Wu XJ; Yu Q
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5990-E5999. PubMed ID: 29891662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia inducible factors in cancer stem cells.
    Heddleston JM; Li Z; Lathia JD; Bao S; Hjelmeland AB; Rich JN
    Br J Cancer; 2010 Mar; 102(5):789-95. PubMed ID: 20104230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem cells and hypoxia-inducible factors (Review).
    Tong WW; Tong GH; Liu Y
    Int J Oncol; 2018 Aug; 53(2):469-476. PubMed ID: 29845228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
    Madden EC; Gorman AM; Logue SE; Samali A
    Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells: a potential target for cancer therapy.
    Qiu H; Fang X; Luo Q; Ouyang G
    Cell Mol Life Sci; 2015 Sep; 72(18):3411-24. PubMed ID: 25967289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-mediated drug resistance in breast cancers.
    McAleese CE; Choudhury C; Butcher NJ; Minchin RF
    Cancer Lett; 2021 Apr; 502():189-199. PubMed ID: 33278499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors.
    Méndez-Blanco C; Fondevila F; García-Palomo A; González-Gallego J; Mauriz JL
    Exp Mol Med; 2018 Oct; 50(10):1-9. PubMed ID: 30315182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells.
    Colak S; Medema JP
    Cell Cycle; 2016 Jun; 15(12):1531-7. PubMed ID: 25483065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of hypoxia-inducible factors in breast cancer stem cell specification.
    Karami Fath M; Garousi S; Mottahedi M; Ghasemzadeh N; Salmani K; Olfati F; Beit Saeed M; Sotoudeh S; Barati G
    Pathol Res Pract; 2023 Mar; 243():154349. PubMed ID: 36791562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia and hypoxia-inducible factors: master regulators of metastasis.
    Lu X; Kang Y
    Clin Cancer Res; 2010 Dec; 16(24):5928-35. PubMed ID: 20962028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical approaches to targeting drug resistance in cancer stem cells.
    Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
    Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.